SLAB · Silicon Laboratories Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $784.76M | $584.39M | $782.26M | $1.02B | $720.86M | $886.68M |
| Cost of Revenue | $327.78M | $272.20M | $321.67M | $381.55M | $295.47M | $359.15M |
| Gross Profit | $456.98M | $312.19M | $460.59M | $642.56M | $425.39M | $527.53M |
| R&D | $353.25M | $332.23M | $337.74M | $332.33M | $273.21M | $287.89M |
| SG&A | $174.28M | $145.45M | $147.00M | $190.97M | $185.02M | $201.34M |
| Total Operating Expenses | $527.52M | $477.68M | $484.74M | $523.30M | $458.23M | $489.23M |
| D&A | $24.72M | $25.55M | $25.71M | $22.52M | $18.05M | $17.78M |
| Operating Income | ($70.54M) | ($165.49M) | ($24.15M) | $119.26M | ($32.84M) | $38.30M |
| Interest Expense | $975.0K | $5.55M | $5.55M | $6.72M | $31.03M | $34.14M |
| Income Tax | $7.00M | $36.20M | $7.94M | $38.45M | $13.43M | $2.77M |
| Net Income | ($64.91M) | ($191.01M) | ($34.52M) | $91.40M | $2.12B | $12.53M |
| EPS - Basic | ($1.98) | ($5.93) | ($1.09) | $2.61 | $49.44 | $0.29 |
| EPS - Diluted | ($1.98) | ($5.93) | ($1.09) | $2.54 | $47.78 | $0.28 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $364.22M | $281.61M | $227.50M | $499.92M | $1.07B | $202.72M |
| Accounts Receivable | $64.51M | $54.48M | $29.30M | $71.44M | $98.31M | $95.17M |
| Inventory | $95.57M | $105.64M | $194.29M | $100.42M | $49.31M | $66.66M |
| Accounts Payable | $50.72M | $42.45M | $57.50M | $89.86M | $47.33M | $54.95M |
| Current Assets | $674.02M | $602.03M | $737.93M | $1.46B | $2.24B | $975.82M |
| Total Assets | $1.27B | $1.22B | $1.44B | $2.17B | $2.96B | $1.99B |
| Current Liabilities | $143.79M | $97.88M | $163.57M | $185.78M | $668.83M | $284.50M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $174.90M | $142.65M | $234.37M | $764.42M | $745.87M | $793.65M |
| Stockholders' Equity | $1.09B | $1.08B | $1.21B | $1.41B | $2.21B | $1.20B |
| Retained Earnings | $936.81M | $1.00B | $1.19B | $1.42B | $2.21B | $993.66M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $95.71M | ($13.91M) | ($30.35M) | $141.27M | ($8.84M) | $135.72M |
| Investing Cash Flow | ($12.03M) | $240.54M | $469.81M | $240.54M | ($358.32M) | ($361.01M) |
| Financing Cash Flow | ($1.07M) | ($45.10M) | ($711.87M) | ($887.05M) | ($1.30B) | $200.87M |
| CapEx | $29.92M | $11.75M | $22.28M | $26.52M | $28.58M | $20.42M |
| Free Cash Flow | $65.79M | ($25.66M) | ($52.63M) | $114.75M | ($37.42M) | $115.30M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 58.2% | 53.4% | 58.9% | 62.7% | 59.0% | 59.5% |
| Operating margin | -9.0% | -28.3% | -3.1% | 11.6% | -4.6% | 4.3% |
| EBITDA margin | -5.8% | -23.9% | 0.2% | 13.8% | -2.1% | 6.3% |
| Net margin | -8.3% | -32.7% | -4.4% | 8.9% | 293.7% | 1.4% |
| Free cash flow margin | 8.4% | -4.4% | -6.7% | 11.2% | -5.2% | 13.0% |
| FCF / Net income | -1.01 | 0.13 | 1.52 | 1.26 | -0.02 | 9.20 |
| R&D / Revenue | 45.0% | 56.9% | 43.2% | 32.5% | 37.9% | 32.5% |
| SG&A / Revenue | 22.2% | 24.9% | 18.8% | 18.6% | 25.7% | 22.7% |
| Effective tax rate | - | - | - | 29.6% | 0.6% | 18.1% |
| Return on assets | -5.1% | -15.6% | -2.4% | 4.2% | 71.6% | 0.6% |
| Return on equity | -5.9% | -17.7% | -2.9% | 6.5% | 95.7% | 1.0% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 4.69 | 6.15 | 4.51 | 7.87 | 3.35 | 3.43 |
| Quick ratio | 4.02 | 5.07 | 3.32 | 7.33 | 3.27 | 3.20 |
| Cash ratio | 2.53 | 2.88 | 1.39 | 2.69 | 1.61 | 0.71 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -72.3x | -29.8x | -4.3x | 17.7x | -1.1x | 1.1x |
| Equity multiplier | 1.16 | 1.13 | 1.19 | 1.54 | 1.34 | 1.66 |
| Liabilities / Assets | 0.14 | 0.12 | 0.16 | 0.35 | 0.25 | 0.40 |
| Efficiency | ||||||
| Asset turnover | 0.62 | 0.48 | 0.54 | 0.47 | 0.24 | 0.44 |
| Inventory turnover | 3.43 | 2.58 | 1.66 | 3.80 | 5.99 | 5.39 |
| Days sales outstanding | 30d | 34d | 14d | 25d | 50d | 39d |
| Days inventory outstanding | 106d | 142d | 220d | 96d | 61d | 68d |
| Days payable outstanding | 56d | 57d | 65d | 86d | 58d | 56d |
| Cash conversion cycle | 80d | 119d | 169d | 36d | 52d | 51d |
| Valuation | ||||||
| P / E | - | - | - | 53.4x | 4.3x | 454.8x |
| P / B | 3.9x | 3.7x | 3.5x | 3.5x | 4.1x | 4.7x |
| P / S | 5.5x | 6.8x | 5.4x | 4.8x | 12.7x | 6.4x |
| EV / EBITDA | - | - | 2562.3x | 31.0x | - | 97.1x |
| Growth | ||||||
| Revenue growth (YoY) | 34.3% | -25.3% | -23.6% | 42.1% | -18.7% | 5.9% |
| Revenue CAGR (3y) | -8.5% | -6.8% | -4.1% | 6.9% | -6.0% | 4.9% |
| Revenue CAGR (5y) | -2.4% | -6.9% | -2.1% | 5.9% | 0.7% | 6.6% |
| Gross profit growth (YoY) | 46.4% | -32.2% | -28.3% | 51.1% | -19.4% | 3.4% |
| Operating income growth (YoY) | 57.4% | -585.1% | - | - | - | -32.4% |
| Net income growth (YoY) | 66.0% | -453.4% | - | -95.7% | 16797.3% | -35.0% |
| EPS growth (YoY) | 66.6% | -444.0% | - | -94.7% | 16964.3% | -34.9% |
| EPS CAGR (3y) | - | - | - | 80.8% | 193.0% | -36.4% |
| EPS CAGR (5y) | - | - | - | 18.4% | 101.2% | -16.5% |
| FCF growth (YoY) | - | 51.2% | - | - | - | -23.3% |
| FCF CAGR (5y) | -10.6% | - | - | -0.3% | - | 4.1% |
| Book value growth (YoY) | 1.3% | -10.6% | -14.0% | -36.5% | 84.4% | 7.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-01-03.
Product / service
$784.76M totalIndustrial Commercial$444.91M · 56.7%
Home Life$339.85M · 43.3%
Geographic
$784.76M totalRest Of World$328.59M · 41.9%
CN$257.10M · 32.8%
TW$130.55M · 16.6%
US$68.52M · 8.7%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
4.00
Safe
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Semiconductors & Related Devices
Comparing SILICON LABORATORIES INC. against the 5 most active filers in the same SIC group.